Conformational analysis of symmetric bilirubin analogues with varying length alkanoic acids. Enantioselectivity by human serum albumin

Abstract

Symmetric analogues of mesobilirubin-XIIIα, with propionic acid groups shortened to acetic and lengthened to undecanoic, exhibit induced circular dichroism (ICD) in pH 7.5 buffered aqueous [1–5% dimethyl sulfoxide (DMSO) co-solvent] solution in the presence of human serum albumin (HSA). The CD spectra exhibit bisignate Cotton effects with ωε^max₄₃₄ = +87, ωε^max₃₈₉ = -54 (acetic), ωε^max₄₃₆ = +37, ωε^max₃₈₈ = -42 (propionic), ωε^max₄₂₀ = -15, ωε^max₃₇₀ = +8 (butyric), [ωε^max₄₃₃ = -97, ωε^max₃₈₈ = +89 in 30% aqueous DMSO], ωε^max₄₄₉ = +6, ωε^max₃₉₇ = -46 (valeric), ωε^max₄₄₀ = +57, ωε^max₃₉₂ = -96 (caproic), ωε^max₄₄₀ = +15, ωε^max₃₉₃ = -21 (caprylic) and ωε^max₄₄₈ = +18, ωε^max₃₈₅ = -31 (undecanoic). These values result from chromophore conformation (i.e. exciton coupling) and enantioselectivity by the protein (i.e. preference for a given bilirubin enantiomer). The UV–VIS spectra of the acetic to butyric, caprylic and undecanoic complexes are similar in shape, with a shoulder in addition to the main band, and reminiscent of that of the bilirubin-IXα HSA complex, indicating an analogous, folded conformation for all. The spectra of the valeric and caproic complexes, in turn, are more symmetric and red-shifted, suggesting a more extended conformation. Experimental CD values in each of these two series have been interpreted in terms of the different enantioselectivity by the protein, with the right handed acetic and caproic enantiomers fitting best the protein binding site (ωωε ca. 150) and the protein showing a lower preference for the right handed propionic enantiomer (ωωε ca. 80) and even lower for the right handed valeric, caprylic and undecanoic enantiomer (ωωε ca. 50), but left handed butyric enantiomer (ωωε ca. 24).The differences observed in the UV–VIS spectra of each complexed (in aqueous buffer) vs. uncomplexed pigment (in MeOH), i.e. spectral shifts (7–11 nm for acetic to butyric and undecanoic, 12 nm for valeric and 16–18 nm for caproic and caprylic) and shape (reduction from two to one transition for valeric and caproic—but not for the rest) reflect the changes in pigment conformation induced by the protein. These changes are especially noticeable for the caproic and caprylic analogues.Taken collectively, the present results indicate that the length of the alkanoic acid chains at C8 and C12 is essential for determining not only the pigment conformation, but also the enantioselectivity by the protein (through specific pigment–protein interactions) and agree with previous suggestions that these interactions may involve (at least) one salt linkage and hydrogen bonding.The effect upon the ICD of each rubin-HSA complex of other parameters such as the percentage of DMSO used as carrier in the solution and the nature of the buffer has also been investigated. Surprisingly, an increase in the amount of DMSO from 3–30% results in dramatic changes in the observed CD of the butyric and (to a lesser extent) propionic, undecanoic complexes. These have been interpreted in terms of selective changes in the tertiary structure of the protein.

References

1. D. A. Lightner and A. F. McDonagh, Acc. Chem. Res., 1984, 17, 417.
2. (a) R. V. Person, B. R. Peterson and D. A. Lightner, J. Am. Chem. Soc., 1994, 116, 42; (b) R. V. Person, PhD Dissertation (Conform-ational Analysis of Bilirubin and its Analogues), University of Nevada, 1993.
3. P. Manitto and D. Monti, J. Chem. Soc., Chem. Commun., 1976, 122.
4. G. Navon, S. Frank and D. Kaplan, J. Chem. Soc., Perkin Trans. 2, 1984, 1145.
5. (a) R. Bonnett, J. E. Davies, N. B. Hursthouse and G. M. Sheldrick, Proc. R. Soc. London, Ser. B, 1978, 202, 249; (b) G. LeBas, A. Allegret, Y. Mauguen, C. DeRango and M. Bailly, Acta Crystallogr., Sect. B, 1980, 36, 3007.
6. R. Brodersen, in Bile Pigments and Jaundice, ed. J. D. Ostrow, Marcel Dekker, New York, 1986; and references therein.
7. G. Blauer, E. Lavie and J. Silfen, Arch. Biochem. Biophys., 1977, 492, 64.
8. For recent reviews, see: Pathobiology of Bilirubin and Jaundice, in J. L. Gollan, (Guest Ed.)Seminars in Liver Disease, Thieme Medical Publishers, Inc., New York, 1988, vol. 8, parts 2 and 3.
9. A. F. McDonagh and D. A. Lightner, Pediatrics, 1985, 75, 443.
10. A. F. McDonagh, in The Porphyrins, ed. D. Dolphin, Academic Press, New York, 1979, vol. VI, p. 293.
11. Bilirubin, eds. K. P. M. Heirwegh and S. B. Brown, CRC Press, Boca Raton, FL, 1982, vols. 1 and 2 and references therein.
12. D. A. Lightner, J. K. Gawronski and W. M. D. Wijekoon, J. Am. Chem. Soc., 1987, 109, 6354.
13. D. A. Lightner, M. Reisinger and G. L. Landen, J. Biol. Chem., 1986, 261, 6034 and references therein.
14. D. A. Lightner, W. M. D. Wijekoon and M.-H. Zhang, J. Biol. Chem., 1988, 263, 16669.
15. G. Puzicha, Y.-M. Pu and D. A. Lightner, J. Am. Chem. Soc., 1991, 113, 3583.
16. (a) G. Blauer, D. Harmatz and J. Snir, Biochim. Biophys. Acta, 1972, 278, 68; (b) G. Blauer and D. Harmatz, Biochim. Biophys. Acta, 1972, 278, 89; (c) D. Harmatz and G. Blauer, Arch. Biochem. Biophys., 1975, 170, 375; (d) G. Blauer and G. Wagnière, J. Am. Chem. Soc., 1975, 97, 1949; (e) G. Blauer, Isr. J. Chem., 1983, 23, 201.
17. J. Jacobsen and R. Brodersen, J. Biol. Chem., 1983, 258, 6319.
18. J. Broos, A. J. W. G. Visser, J. F. J. Engbersen, W. Verboom, A. van Hock and D. N. Reinhoudt, J. Am. Chem. Soc., 1995, 117, 12657.
19. H. Murakawa, J. Abe, A. Seki and H. Takahashi, J. Mol. Struct., 1993, 297, 41.
20. F. R. Trull, D. P. Shrout and D. A. Lightner, Tetrahedron, 1992, 48, 8189.
21. J.-S. Ma and D. A. Lightner, J. Heterocycl. Chem., 1984, 21, 1005.
22. M. Fontich, M. Rodríguez and F. R. Trull, Synth. Commun., 1994, 24, 993.
23. M. Reisinger, F. R. Trull and D. A. Lightner, J. Heterocycl. Chem., 1985, 22, 1221.
24. F. R. Trull, M. Rodríguez and D. A. Lightner, Synth. Commun., 1993, 23, 2771.
25. F. R. Trull, R. W. Franklin and D. A. Lightner, J. Heterocycl. Chem., 1987, 24, 1573.
26. D. P. Shrout, G. Puzicha and D. A. Lightner, Synthesis, 1992, 3, 328.
27. J. Chiefari, R. V. Person and D. A. Lightner, Tetrahedron, 1992, 48, 5969.
28. W. L. Shelver, H. Rosenberg and W. H. Shelver, Int. J. Quantum Chem., 1992, 44, 141.
29. D. A. Lightner, R. V. Person, B. R. Peterson, G. Puzicha, Y.-M. Pu and S. E. Bojadziev, Biomolecular Spectroscopy II, eds. R. R. Birge and L. A. Nafie, Proc. SPIE, 1991, 1432, 2.
30. R. V. Person, S. E. Boiadjiev, B. R. Peterson, G. Puzicha and D. A. Lightner, 4th International Conference on Circular Dichroism, Sept. 9–13, 1991, Bochum, FRG, p. 55.
31. M. Kasha, H. R. Rawls and M. A. El-Bayoumi, Pure Appl. Chem., 1965, 32, 371.
32. N. Harada and K. Nakanishi, Circular Dichroic Spectroscopy-Exciton Coupling in Organic Stereochemistry, University Science Books, Mill Valley, CA, 1983.
33. Data from reverse-phase HPLC column using a 0.1 m di-octyl-ammonium acetate in MeOH buffer with 5% water at pH 7.7 according to A. F. McDonagh, L. A. Palma, F. R. Trull and D. A. Lightner, J. Am. Chem. Soc., 1982, 104, 6865.
34. S. E. Boiadjiev, R. V. Person, G. Puzicha, C. Knobler, E. Maverick, K. N. Trueblood and D. A. Lightner, J. Am. Chem. Soc., 1992, 114, 10123.
35. Y.-M. Pu, A. F. McDonagh and D. A. Lightner, J. Am. Chem. Soc., 1993, 115, 377.
36. H. Falk, T. Schlederer and P. Wolschann, Monatsch Chem., 1981, 112, 199.